SymbolMGX
NameMETAGENOMI, INC.
SectorHEALTH CARE
RegionNorth America
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
Address5959 HORTON STREET,7TH FLOOR, EMERYVILLE, California, 94608, United States
Telephone+1 510 871-4880
Fax
Email
Websitehttps://metagenomi.co
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001785279
Description

At Metageno-mi, we are cre-at-ing poten-tial-ly cura-tive ther-a-peu-tics using our metage--nomics-pow-ered genome edit-ing toolbox.We believe tools with capa-bil-i-ties that go beyond the cur-rent tech-nol-o-gy land-scape will be required in order to reach the full ther-a-peu-tic poten-tial of genome edit-ing. By har-ness-ing the pow-er of metage-nomics, the study of genomes recov-ered from uncul-ti-vat-ed organ-isms in the nat-ur-al envi-ron-ment, we are dis-cov-er-ing and devel-op-ing a suite of nov-el genome edit-ing tools with the poten-tial to make any desired ther-a-peu-tic gene edit, any-where in the human genome.

Additional info from NASDAQ:
Metagenomi Therapeutics, Inc. is an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients. The Company was founded on the science of metagenomics, the study of genetic materials recovered from the natural environment, to discover and develop a suite of novel editing tools potentially capable of correcting any type of genetic mutation found anywhere in the human genome. The Company focuses on high value programs in disease indications with well-understood biology and clearly defined clinical development and regulatory pathways. Going forward, the Company intends to continue to expand its pipeline by leveraging its proprietary genetic editing capabilities in site specific deletion, integration and correction.

Additional info from NASDAQ:
At Metageno-mi, we are cre-at-ing poten-tial-ly cura-tive ther-a-peu-tics using our metage--nomics-pow-ered genome edit-ing toolbox.We believe tools with capa-bil-i-ties that go beyond the cur-rent tech-nol-o-gy land-scape will be required in order to reach the full ther-a-peu-tic poten-tial of genome edit-ing. By har-ness-ing the pow-er of metage-nomics, the study of genomes recov-ered from uncul-ti-vat-ed organ-isms in the nat-ur-al envi-ron-ment, we are dis-cov-er-ing and devel-op-ing a suite of nov-el genome edit-ing tools with the poten-tial to make any desired ther-a-peu-tic gene edit, any-where in the human genome.

2026-06-11 18:31

Reid Laurence 🟢 acquired 17.4K shares (1 derivative) of Metagenomi Therapeutics, Inc. (MGX) at $1.23 Transaction Date: Jun 09, 2026 | Filing ID: 267272

Read more
2026-06-11 18:23

Dere Willard H 🟢 acquired 21.0K shares (1 derivative) of Metagenomi Therapeutics, Inc. (MGX) at $1.23 Transaction Date: Jun 09, 2026 | Filing ID: 267255

Read more
2026-06-11 17:49

BJERKHOLT ERIC 🟢 acquired 21.0K shares (1 derivative) of Metagenomi Therapeutics, Inc. (MGX) at $1.23 Transaction Date: Jun 09, 2026 | Filing ID: 267189

Read more
2026-06-11 17:37

Eckhardt Juergen 🟢 acquired 21.0K shares (1 derivative) of Metagenomi Therapeutics, Inc. (MGX) at $1.23 Transaction Date: Jun 09, 2026 | Filing ID: 267170

Read more
2026-06-10 15:23

Wapnick Pamela 🔴 sold 2.9K shares of Metagenomi Therapeutics, Inc. (MGX) at $1.30 Transaction Date: Jun 05, 2026 | Filing ID: 265335

Read more
2026-06-10 15:21

Irish Jian 🔴 sold 3.7K shares of Metagenomi Therapeutics, Inc. (MGX) at $1.30 Transaction Date: Jun 05, 2026 | Filing ID: 265332

Read more
2026-06-10 15:19

Wein Matthew 🔴 sold 558 shares of Metagenomi Therapeutics, Inc. (MGX) at $1.30 Transaction Date: Jun 05, 2026 | Filing ID: 265326

Read more
2026-05-11 20:09

(30% Negative) METAGENOMI, INC. (MGX) Reports Q2 2026 Financial Results

Read more
2026-05-11 20:05

Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial Results

Read more
2026-04-27 17:59

New Form ARS - Metagenomi Therapeutics, Inc. <b>Filed:</b> 2026-04-27 <b>AccNo:</b> 0001193125-26-182345 <b>Size:</b> 4 MB

Read more